Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 13 h ago

LIFECORE BIOMEDICAL, INC. \DE\: Greenhaven Road Investment Management, L.P. amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Greenhaven Road Investment Management, L.P. amended its Schedule 13G stake filing for Lifecore Biomedical, Inc. (SEC accession 0000919574-26-008139), updating its previously reported beneficial ownership position in the company. The filing reflects a change to the investment firm's passive stake rather than an activist position, though the amended document did not disclose a revised share count or percentage in the headline details. The update matters because 13G amendments signal shifts in institutional ownership that can influence liquidity and investor sentiment in the small-cap biomedical supplier. Watchers should review the full filing for the exact share total and ownership percentage, and monitor whether further amendments follow.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

LIFECORE BIOMEDICAL, INC., Greenhaven Road Investment Management, L.P.